Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: AMERISOURCEBERGEN DRUG CORP
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2023-12-28 to 2023-12-29
Current total value of award: $7537.69
Description: 4563194218!QUILLIVANT XR ORAL SUSP 60ML 5MG/ML